Agathangelidis, Andreas https://orcid.org/0000-0002-8467-7945
Iatrou, Anastasia https://orcid.org/0000-0002-8995-4454
Pechlivanis, Nikolaos https://orcid.org/0000-0003-2502-612X
Karakatsoulis, Georgios https://orcid.org/0000-0002-8496-3087
Zaragoza-Infante, Laura https://orcid.org/0000-0003-0207-257X
Galigalidou, Chrysi
Maity, Palash Chandra
Ranghetti, Pamela
Almeida, Julia https://orcid.org/0000-0003-3124-8917
Fuentes-Herrero, Blanca
Navarro, Almudena https://orcid.org/0000-0002-7972-5666
Alcoceba, Miguel https://orcid.org/0000-0002-3819-4846
Rabbani, Leily https://orcid.org/0009-0007-0755-3643
Thorvaldsdottir, Birna https://orcid.org/0000-0001-7372-9925
Scarfò, Lydia https://orcid.org/0000-0002-0844-0989
Orfao, Alberto https://orcid.org/0000-0002-0007-7230
Psomopoulos, Fotis https://orcid.org/0000-0002-0222-4273
Jumaa, Hassan https://orcid.org/0000-0003-3383-141X
Rosenquist, Richard https://orcid.org/0000-0002-0211-8788
Chatzidimitriou, Anastasia
Ghia, Paolo https://orcid.org/0000-0003-3750-7342
Stamatopoulos, Kostas https://orcid.org/0000-0001-8529-640X
Article History
Received: 24 April 2025
Revised: 20 September 2025
Accepted: 27 October 2025
First Online: 7 January 2026
Competing interests
: R.R. has received honoraria from AbbVie, AstraZeneca, Janssen, Illumina, and Roche. P. G. reports fees for consulting and honoraria from AbbVie, AstraZeneca, BeiGene, Bristol Myers Squibb, Janssen, Loxo@Lilly, Merck Sharp & Dohme Corp., and Roche; and research funding from AbbVie, AstraZeneca, and Janssen. K.S. has received honoraria from AbbVie, AstraZeneca, Janssen; research support from AbbVie, AstraZeneca, Gilead Sciences, Janssen, and Roche. The other authors declare no conflicts of interest.
: All methods were performed in accordance with the relevant guidelines and regulations. Approval has been obtained from the Ethics Review Committee of the Centre for Research & Technology Hellas (Reference No: ETH.COM-64). Informed consent was obtained from all study participants.